Sun Pharma Advanced Research Company Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
8
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 11, 2027The maintenance fee for Cysteinyl leukotriene antagonists (US 9,102,665) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Treatment for Parkinson's disease (US 11,813,252) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Stabilization of phenobarbital sodium for injection (US 11,857,683) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 2 fees due Aug 6 to 23, 2027 · next Aug 6
- 1 fee due Sep 19, 2027The maintenance fee for Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (US 11,931,359) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
- 1 fee due Oct 9, 2027The maintenance fee for Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (US 11,951,106) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
Recent changes
- 3 terms have ended since Aug 22, 2026
- Oct 11 US 11,465,990 Novel Heterocyclic Antiestrogens · lapsed on the fee record
- Sep 13 US 11,439,600 Abuse Deterrent Oral Solid Dosage Form · lapsed on the fee record
- Sep 6 US 10,213,387 Oral Drug Delivery System · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,345 | Gastric Retention Controlled Drug Delivery System In force · High confidence | In force | High confidence | |
| US 8,163,306 | Oral Drug Delivery System In force · High confidence | In force | High confidence | |
| US 8,431,156 | Pharmaceutical composition In force · USPTO record | In force | USPTO record | |
| US 8,470,367 | Oral drug delivery system In force · Medium confidence | In force | Medium confidence | |
| US 10,226,428 | Oral Drug Delivery System In force · Low confidence | In force | Low confidence | |
| US 9,539,262 | Ophthalmic composition comprising a prostaglandin In force · USPTO record | In force | USPTO record | |
| US 9,629,852 | Ophthalmic composition comprising a prostaglandin In force · USPTO record | In force | USPTO record | |
| US 9,439,851 | Gastric Retention System In force · High confidence | In force | High confidence | |
| US 9,024,021 | Diarylacetylene Hydrazide Containing Tyrosine Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 9,266,867 | Piperidinyl monocarboxylic acids as S1P1 receptor agonists In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 33: 1 patent in force now held by others · 26 lapsed for an unpaid fee · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 2 abandoned · 30 no status recorded